Should you buy these FTSE 250 stocks before next week’s updates?

Royston Wild looks at two FTSE 250 stocks in the run-up to next week’s releases.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Outsourcing giant Mitie Group (LSE: MTE) shocked us all back in September when it issued a surprise profit warning on the back of deteriorating market conditions.

Shares in the business slumped to their cheapest since the spring of 2009 in the days following the release, and the news also prompted the resignation of long-time chief executive Ruby McGregor-Smith.

Mitie Group advised that “we continue to experience the effects of significant economic pressures,” the firm noting “lower UK growth rates, changes to labour legislation and further public sector budget constraints, and uncertainty both pre and post the EU referendum.”

As a consequence Mitie advised that “in the first half we expect revenue to be modestly lower and operating profit to be very significantly lower.”

The support services provider’s report for the period spanning April-September is scheduled for release on 21 November. And it’s quite possible that Mitie will report a further deterioration in trading conditions as uncertainty following June’s referendum delays investment decisions by British businesses.

The City expects Mitie to endure a 19% earnings collapse in the year to March 2017, and I believe the complexity of the UK’s Brexit negotiations could hinder any earnings recovery, in the near term at least.

As such, I reckon investors should give the firm short shrift, even though the firm deals on a modest forward P/E ratio of 10.4 times. I reckon further downgrades to bottom-line forecasts are a very real possibility in the weeks and months ahead.

Global goliath

Conversely, I reckon investors should consider snapping up Homeserve (LSE: HSV) prior to the firm’s half-year report (currently slated for 22 November).

The emergency call-out play remains anchored near this month’s peaks of 622p per share, the highest since the five-for-one share split back in 2010. And I reckon next week’s release could prompt a surge to new recent tops.

Homeserve announced in July that “the group is trading in line with our expectations and we expect to deliver good growth in the year ending 31 March 2017.” Huge investment in marketing is helping to build the firm’s customer base, but this is only part of the story as Homeserve has a knack of retaining the bulk of its clients — indeed, retention rates in the US and UK clocked in north of 80% in the last fiscal year.

Meanwhile, the acquisition of United Service Partners (or USP) in July has bolstered the repairs giant’s position in North America quite considerably. The move expands its customer base by 400,000, and takes the number of clients on its books to 2.7m.

Accordingly the number crunchers expect it to continue clocking up double-digit earnings growth in the medium term, and a 14% advance is pencilled-in for fiscal 2017 alone.

A subsequent P/E rating of 24.3 times may not leave much room for the shares to climb, at least from a conventional standpoint — this reading sails above the benchmark of 15 times that indicates ‘attractive’ value.

Still, Homeserve’s strong progress across Europe and in the US merits a loftier rating, in my opinion, and I reckon the firm has what it takes to post strong stock value advances in the years ahead.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Homeserve. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »